Published in Ann Surg on September 01, 2011
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg (2016) 2.05
Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB (Oxford) (2012) 1.03
Hepatocellular carcinoma--resection or transplant? Nat Rev Gastroenterol Hepatol (2012) 0.92
Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma. World J Gastroenterol (2012) 0.86
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85
Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma. Cell Death Dis (2015) 0.84
The effects of sorafenib on liver regeneration in a model of partial hepatectomy. J Surg Res (2012) 0.82
Transplant benefit for patients with hepatocellular carcinoma. World J Gastroenterol (2013) 0.81
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun. Surg Today (2016) 0.81
Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy. World J Surg (2013) 0.80
INFLUENCE OF HEPATOCELLULAR CARCINOMA ETIOLOGY IN THE SURVIVAL AFTER RESECTION. Arq Bras Cir Dig (2016) 0.80
Laparoscopic resection for hepatocellular carcinoma: eastern and western experiences. Chin J Cancer Res (2014) 0.79
Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter. HPB (Oxford) (2014) 0.78
Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma. World J Surg (2014) 0.77
Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis Markers (2015) 0.77
Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma. World J Surg Oncol (2015) 0.76
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy. Liver Cancer (2015) 0.76
Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries. World J Hepatol (2016) 0.75
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis (2014) 0.75
Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis. Medicine (Baltimore) (2016) 0.75
Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. HPB (Oxford) (2013) 0.75
Resection or Transplant in Early Hepatocellular Carcinoma. Dtsch Arztebl Int (2017) 0.75
Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria. World J Surg (2012) 0.75
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Hepatocellular carcinoma: recent trends in the United States. Gastroenterology (2004) 5.90
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg (2006) 5.65
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg (2010) 4.75
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology (1997) 3.10
Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg (2011) 3.10
Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg (2009) 2.30
Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04
Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg (2003) 2.03
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02
Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg (2010) 2.01
Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00
Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol (2005) 1.94
Liver regeneration. J Am Coll Surg (2003) 1.79
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg (2000) 1.49
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg (2007) 1.38
Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology (2009) 1.31
Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl (2003) 1.24
Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology (2007) 1.20
Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Lett (2006) 1.19
Molecular pathogenesis of hepatocellular carcinoma. J Surg Res (2006) 1.15
Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol (2011) 1.12
An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol (2007) 1.11
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol (2008) 1.08
Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg (2006) 1.04
Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res (2007) 1.03
Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) (2009) 1.02
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol (2008) 1.00
Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology (2002) 0.99
Laparoscopic liver resection--current update. Surg Clin North Am (2010) 0.97
Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg (2010) 0.92
Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression. Cell Transplant (2006) 0.89
Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol (2002) 0.83
An analysis of liver transplant survival rates from the UNOS registry. Clin Transpl (2008) 0.77
Inadequate anaesthesia in lethal injection for execution. Lancet (2005) 3.98
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer (2012) 3.12
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery. Surgery (2008) 2.81
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
Can lethal injection for execution really be "fixed"? Lancet (2007) 2.33
When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg (2014) 2.23
Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol (2006) 2.08
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg (2006) 1.90
Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res (2007) 1.82
Regulation of muscle mass by follistatin and activins. Mol Endocrinol (2010) 1.79
Liver regeneration. J Am Coll Surg (2003) 1.79
Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol (2003) 1.62
Intestinal transplantation for the treatment of neoplastic disease. J Surg Oncol (2005) 1.62
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol (2008) 1.60
Getting actionable about community resilience: the Los Angeles County Community Disaster Resilience project. Am J Public Health (2013) 1.59
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer (2008) 1.57
Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol (2012) 1.57
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol (2007) 1.55
Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg (2007) 1.55
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood (2012) 1.53
The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc (2011) 1.52
Transplantation of the abdominal wall. Lancet (2003) 1.51
Does surgery or radiation therapy impact survival for patients with extrapulmonary small cell cancers? J Surg Oncol (2011) 1.50
Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients. Ann Surg (2008) 1.50
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg (2007) 1.48
Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res (2012) 1.45
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun (2009) 1.45
Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus? Ann Surg Oncol (2009) 1.44
Breast cancer in limited-resource countries: early detection and access to care. Breast J (2006) 1.43
Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. Transplantation (2002) 1.42
Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transpl (2004) 1.42
Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry (2004) 1.41
Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol (2006) 1.40
Analysis of vascular access in intestinal transplant recipients using the Miami classification from the VIIIth International Small Bowel Transplant Symposium. Transplantation (2005) 1.40
Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma. Arch Surg (2010) 1.39
Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled veterans. Health Serv Res (2010) 1.37
100 multivisceral transplants at a single center. Ann Surg (2005) 1.34
Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock (2005) 1.31
A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation (2004) 1.30
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation (2003) 1.28
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation (2005) 1.25
Intestinal and multivisceral transplantation. World J Surg (2001) 1.25
Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer (2010) 1.25
Surgical management of primary breast sarcoma. Am Surg (2002) 1.24
Overweight and obesity in women with physical disabilities: associations with demographic and disability characteristics and secondary conditions. Disabil Health J (2008) 1.22
Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation (2006) 1.22
Intestinal and multivisceral transplantation in children. Ann Surg (2006) 1.22
Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology (2007) 1.20
Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget (2012) 1.20
Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut (2008) 1.16
Molecular pathogenesis of hepatocellular carcinoma. J Surg Res (2006) 1.15
Lasers in the treatment of nonmelanoma skin cancer. Dermatol Surg (2011) 1.11
Angiosarcomas of the breast: a review of 70 cases. Am J Clin Oncol (2007) 1.11
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation (2002) 1.11
Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol (2007) 1.10
Does poorer familiarity with Medicare translate into worse access to health care? J Am Geriatr Soc (2008) 1.09
Disparities in survival after female breast cancer diagnosis: a population-based study. Cancer Causes Control (2013) 1.09
The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol (2009) 1.09
Male breast cancer: is the incidence increasing? Ann Surg Oncol (2004) 1.08
Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry (2004) 1.07
Body surface area prediction in normal, hypermuscular, and obese mice. J Surg Res (2008) 1.07
Applying community engagement to disaster planning: developing the vision and design for the Los Angeles County Community Disaster Resilience initiative. Am J Public Health (2013) 1.06
Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation (2011) 1.06
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res (2011) 1.06
Intrahepatic biliary strictures after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.05
Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg (2006) 1.04
Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Arthritis Rheum (2008) 1.03
Donor intracaval thrombus formation and pulmonary embolism after simultaneous piggyback liver transplantation and aortic valve replacement. Clin Transplant (2003) 1.02
Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood (2013) 1.01
Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr (2006) 1.01
The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01
Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol (2011) 1.01
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol (2008) 1.00
Scientific impact of women in academic surgery. J Surg Res (2008) 1.00
The use of Campath-1H as induction therapy in renal transplantation: preliminary results. Transplantation (2004) 0.99
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation (2004) 0.99
Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology (2006) 0.98
Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg (2002) 0.98
VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care (2009) 0.98
Perspective: PhD scientists completing medical school in two years: looking at the Miami PhD-to-MD program alumni twenty years later. Acad Med (2010) 0.97